111 related articles for article (PubMed ID: 8692736)
1. Theoretical design of prodrug-enhancer combination based on a skin diffusion model: prediction of permeation of acyclovir prodrugs treated with 1-geranylazacycloheptan-2-one.
Bando H; Takagi T; Yamashita F; Takakura Y; Hashida M
Pharm Res; 1996 Mar; 13(3):427-32. PubMed ID: 8692736
[TBL] [Abstract][Full Text] [Related]
2. Skin penetration enhancement of acyclovir by prodrug-enhancer combination.
Bando H; Yamashita F; Takakura Y; Hashida M
Biol Pharm Bull; 1994 Aug; 17(8):1141-3. PubMed ID: 7820127
[TBL] [Abstract][Full Text] [Related]
3. In vivo and in vitro analysis of skin penetration enhancement based on a two-layer diffusion model with polar and nonpolar routes in the stratum corneum.
Yamashita F; Bando H; Koyama Y; Kitagawa S; Takakura Y; Hashida M
Pharm Res; 1994 Feb; 11(2):185-91. PubMed ID: 8165175
[TBL] [Abstract][Full Text] [Related]
4. In vivo evaluation of acyclovir prodrug penetration and metabolism through rat skin using a diffusion/bioconversion model.
Bando H; Sahashi M; Yamashita F; Takakura Y; Hashida M
Pharm Res; 1997 Jan; 14(1):56-62. PubMed ID: 9034221
[TBL] [Abstract][Full Text] [Related]
5. Analysis of skin penetration enhancement based on a two-layer skin diffusion model with polar and nonpolar routes in the stratum corneum: dose-dependent effect of 1-geranylazacycloheptan-2-one on drugs with different lipophilicities.
Yamashita F; Yoshioka T; Koyama Y; Okamoto H; Sezaki H; Hashida M
Biol Pharm Bull; 1993 Jul; 16(7):690-7. PubMed ID: 8401404
[TBL] [Abstract][Full Text] [Related]
6. Evaluation of stereoselective transdermal transport and concurrent cutaneous hydrolysis of several ester prodrugs of propranolol: mechanism of stereoselective permeation.
Ahmed S; Imai T; Otagiri M
Pharm Res; 1996 Oct; 13(10):1524-9. PubMed ID: 8899845
[TBL] [Abstract][Full Text] [Related]
7. Percutaneous penetration of acyclovir through excised hairless mouse and rat skin: effect of vehicle and percutaneous penetration enhancer.
Okamoto H; Muta K; Hashida M; Sezaki H
Pharm Res; 1990 Jan; 7(1):64-8. PubMed ID: 2300538
[TBL] [Abstract][Full Text] [Related]
8. Transdermal delivery of nalbuphine and its prodrugs by electroporation.
Sung KC; Fang JY; Wang JJ; Hu OY
Eur J Pharm Sci; 2003 Jan; 18(1):63-70. PubMed ID: 12554074
[TBL] [Abstract][Full Text] [Related]
9. Bile salt-fatty acid mixed micelles as nasal absorption promoters. III. Effects on nasal transport and enzymatic degradation of acyclovir prodrugs.
Shao Z; Mitra AK
Pharm Res; 1994 Feb; 11(2):243-50. PubMed ID: 8165183
[TBL] [Abstract][Full Text] [Related]
10. The physicochemical properties, plasma enzymatic hydrolysis, and nasal absorption of acyclovir and its 2'-ester prodrugs.
Shao Z; Park GB; Krishnamoorthy R; Mitra AK
Pharm Res; 1994 Feb; 11(2):237-42. PubMed ID: 8165182
[TBL] [Abstract][Full Text] [Related]
11. In vitro percutaneous absorption of arildone, a highly lipophilic drug, and the apparent no-effect of the penetration enhancer Azone in excised human skin.
Baker EJ; Hadgraft J
Pharm Res; 1995 Jul; 12(7):993-7. PubMed ID: 7494819
[TBL] [Abstract][Full Text] [Related]
12. Novel cyclosporin derivatives featuring enhanced skin penetration despite increased molecular weight.
Billich A; Vyplel H; Grassberger M; Schmook FP; Steck A; Stuetz A
Bioorg Med Chem; 2005 May; 13(9):3157-67. PubMed ID: 15809151
[TBL] [Abstract][Full Text] [Related]
13. Physicochemical evaluation, in vitro human skin diffusion, and concurrent biotransformation of 3-O-alkyl carbonate prodrugs of naltrexone.
Pillai O; Hamad MO; Crooks PA; Stinchcomb AL
Pharm Res; 2004 Jul; 21(7):1146-52. PubMed ID: 15290853
[TBL] [Abstract][Full Text] [Related]
14. The effect of formulation excipients on the penetration and lateral diffusion of ibuprofen on and within the stratum corneum following topical application to humans.
Gee CM; Watkinson AC; Nicolazzo JA; Finnin BC
J Pharm Sci; 2014 Mar; 103(3):909-19. PubMed ID: 24421242
[TBL] [Abstract][Full Text] [Related]
15. Ketorolac amide prodrugs for transdermal delivery: stability and in vitro rat skin permeation studies.
Kim BY; Doh HJ; Le TN; Cho WJ; Yong CS; Choi HG; Kim JS; Lee CH; Kim DD
Int J Pharm; 2005 Apr; 293(1-2):193-202. PubMed ID: 15778057
[TBL] [Abstract][Full Text] [Related]
16. Utilization of nanotechnology to enhance percutaneous absorption of acyclovir in the treatment of herpes simplex viral infections.
Al-Subaie MM; Hosny KM; El-Say KM; Ahmed TA; Aljaeid BM
Int J Nanomedicine; 2015; 10():3973-85. PubMed ID: 26109856
[TBL] [Abstract][Full Text] [Related]
17. Transcorneal permeation of L- and D-aspartate ester prodrugs of acyclovir: delineation of passive diffusion versus transporter involvement.
Majumdar S; Hingorani T; Srirangam R; Gadepalli RS; Rimoldi JM; Repka MA
Pharm Res; 2009 May; 26(5):1261-9. PubMed ID: 18839288
[TBL] [Abstract][Full Text] [Related]
18. Synthesis and evaluation of Ketorolac ester prodrugs for transdermal delivery.
Doh HJ; Cho WJ; Yong CS; Choi HG; Kim JS; Lee CH; Kim DD
J Pharm Sci; 2003 May; 92(5):1008-17. PubMed ID: 12712420
[TBL] [Abstract][Full Text] [Related]
19. Effect of the absorption enhancer, Azone, on the transport of 5-fluorouracil across hairless rat skin.
Sugibayashi K; Hosoya K; Morimoto Y; Higuchi WI
J Pharm Pharmacol; 1985 Aug; 37(8):578-80. PubMed ID: 2864423
[TBL] [Abstract][Full Text] [Related]
20. [Influence of penetration enhancers on in vitro transdermal permeation of L-tethrahydropalmatine].
Qian L; Ma Z; Zhang W; Wang Q
Zhongguo Zhong Yao Za Zhi; 2011 Jul; 36(13):1729-32. PubMed ID: 22032134
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
